![Scott M. Brown](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott M. Brown
Gründer bei Biologics Process Development, Inc.
Profil
Scott M.
Brown is the founder of Biologics Process Development, Inc. which was founded in 1996, where he holds the title of President & Chief Scientific Officer.
He also worked as Director & Chief Scientific Officer at Viropro, Inc. from 2011 to 2012.
Dr. Brown earned a doctorate degree from the University of California, Los Angeles.
Aktive Positionen von Scott M. Brown
Unternehmen | Position | Beginn |
---|---|---|
Biologics Process Development, Inc.
![]() Biologics Process Development, Inc. Pharmaceuticals: MajorHealth Technology Part of Viropro, Inc., Biologics Process Development, Inc. is a company that manufactures biotechnical products. The company is based in Poway, CA. The company was founded by Scott M. Brown. Biologics Process Development was acquired by Viropro, Inc. from Intas Pharmaceuticals Ltd. on April 14, 2010 for $1.47 million. | Gründer | 01.01.1996 |
Ehemalige bekannte Positionen von Scott M. Brown
Unternehmen | Position | Ende |
---|---|---|
VIROPRO INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Scott M. Brown
University of California, Los Angeles | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VIROPRO INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Biologics Process Development, Inc.
![]() Biologics Process Development, Inc. Pharmaceuticals: MajorHealth Technology Part of Viropro, Inc., Biologics Process Development, Inc. is a company that manufactures biotechnical products. The company is based in Poway, CA. The company was founded by Scott M. Brown. Biologics Process Development was acquired by Viropro, Inc. from Intas Pharmaceuticals Ltd. on April 14, 2010 for $1.47 million. | Health Technology |